Wendelin Schramm
Wendelin Schramm
GECKO Institue Hochschule Heilbronn
Verified email at
Cited by
Cited by
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)
S Martin, W Schramm, B Schneider, K Neeser, C Weber, V Lodwig, ...
Experimental and clinical endocrinology & diabetes 115 (08), 495-501, 2007
Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program
B Kulzer, W Daenschel, I Daenschel, W Schramm, D Messinger, ...
diabetes research and clinical practice 144, 200-212, 2018
Screening of diabetic patients for microalbuminuria in primary care—The PROSIT-Project
W Piehlmeier, R Renner, W Schramm, T Kimmerling, S Garbe, ...
Experimental and clinical endocrinology & diabetes 107 (04), 244-251, 1999
Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a German statutory healthcare perspective
K Neeser, G Lübben, U Siebert, W Schramm
Pharmacoeconomics 22 (5), 321-341, 2004
Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most …
K Neeser, T Szucs, JL Bulliard, G Bachmann, W Schramm
Value in health 10 (1), 42-53, 2007
A method for using real world data in breast cancer modeling
M Pobiruchin, S Bochum, UM Martens, M Kieser, W Schramm
Journal of Biomedical Informatics 60, 385-394, 2016
Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the ninth mount hood diabetes challenge
L Si, MS Willis, C Asseburg, A Nilsson, M Tew, PM Clarke, M Lamotte, ...
Value in Health 23 (9), 1163-1170, 2020
The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood
S Kent, F Becker, T Feenstra, A Tran-Duy, I Schlackow, M Tew, P Zhang, ...
Pharmacoeconomics 37 (11), 1305-1312, 2019
Integrated Personalized Diabetes Management (PDM) Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the …
B Kulzer, W Daenschel, I Daenschel, EG Siegel, W Schramm, CG Parkin, ...
Journal of diabetes science and technology 10 (3), 772-781, 2016
Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease
W Schramm, D Haake, A Brandt
Praxis 94 (46), 1803-1810, 2005
PROSIT Open Source Disease Models for Diabetes Mellitus.
W Schramm, F Sailer, M Pobiruchin, C Weiss
ICIMTH, 115-118, 2016
35th Annual Meeting of the European Association for the Study of Diabetes
A Melander, J Olsson, G Lindberg, A Salzman, T Howard, P Stang, ...
Diabetologia 42 (1), A1-A330, 1999
Prediction of 5-Year Survival with Data Mining Algorithms.
F Sailer, M Pobiruchin, S Bochum, UM Martens, W Schramm
ICIMTH, 75-78, 2015
Assessment of SARS-CoV-2 infection among healthcare workers of a German COVID-19 treatment center
L Larribère, J Gordejeva, L Kuhnhenn, M Kurscheidt, M Pobiruchin, ...
International Journal of Environmental Research and Public Health 18 (13), 7057, 2021
Benefit of digital tools used for integrated personalized diabetes management: results from the PDM-ProValue study program
L Heinemann, W Schramm, H Koenig, A Moritz, I Vesper, J Weissmann, ...
Journal of Diabetes Science and Technology 14 (2), 240-249, 2020
Digital diabetes self-management: a trilateral serial
W Schramm
Journal of Diabetes Science and Technology 12 (3), 709-711, 2018
Integrated personalized diabetes management (iPDM) in patients with insulin-treated T2DM: Results of the PDM-ProValue study program
L Heinemann, I Daenschel, W Dänschel, D Messinger, W Schramm, ...
11th International Conference on Advanced Technologies & Treatments for …, 2018
Self-monitoring of blood glucose: one STeP forward?
W Schramm
Journal of Diabetes Science and Technology 6 (4), 978-982, 2012
First referral of diabetic patients to a nephrologist
W Schramm, H Bergrem, P Cromme, T Feest, K Borch‐Johnsen, ...
Diabetic Medicine 20 (8), 689-690, 2003
PROSIT--a quality management system for diabetic patients with nephropathy in Germany.
W Piehlmeier, R Renner, W Schramm, A Schneider, A König, ...
Diabetes, Nutrition & Metabolism 14 (2), 110-114, 2001
The system can't perform the operation now. Try again later.
Articles 1–20